Search alternatives:
significantly weaker » significantly greater (Expand Search), significantly better (Expand Search), significantly related (Expand Search)
smaller decrease » marked decrease (Expand Search), smaller areas (Expand Search), larger decrease (Expand Search)
weaker decrease » greater decrease (Expand Search), teer decrease (Expand Search), water decreases (Expand Search)
small decrease » small increased (Expand Search)
Showing 461 - 480 results of 1,516 for search '(( significantly weaker decrease ) OR ( significantly ((smaller decrease) OR (small decrease)) ))', query time: 0.48s Refine Results
  1. 461
    Table 3_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.xlsx

    Table 3_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.xlsx by Joanna Palade (17712960)

    Published 2025
    “…Introduction<p>Immune-based agents, especially Immune Checkpoint Inhibitors (ICI), are standard of care therapy in non-small cell lung cancers (NSCLC); however, a significant number of patient tumors fail to respond, or develop resistance. …”
    Save to List
    Saved in:
  2. 462
    Table 7_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.xlsx

    Table 7_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.xlsx by Joanna Palade (17712960)

    Published 2025
    “…Introduction<p>Immune-based agents, especially Immune Checkpoint Inhibitors (ICI), are standard of care therapy in non-small cell lung cancers (NSCLC); however, a significant number of patient tumors fail to respond, or develop resistance. …”
    Save to List
    Saved in:
  3. 463
    Image 1_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.jpg

    Image 1_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.jpg by Joanna Palade (17712960)

    Published 2025
    “…Introduction<p>Immune-based agents, especially Immune Checkpoint Inhibitors (ICI), are standard of care therapy in non-small cell lung cancers (NSCLC); however, a significant number of patient tumors fail to respond, or develop resistance. …”
    Save to List
    Saved in:
  4. 464
    Table 8_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.xlsx

    Table 8_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.xlsx by Joanna Palade (17712960)

    Published 2025
    “…Introduction<p>Immune-based agents, especially Immune Checkpoint Inhibitors (ICI), are standard of care therapy in non-small cell lung cancers (NSCLC); however, a significant number of patient tumors fail to respond, or develop resistance. …”
    Save to List
    Saved in:
  5. 465
    Table 4_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.xlsx

    Table 4_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.xlsx by Joanna Palade (17712960)

    Published 2025
    “…Introduction<p>Immune-based agents, especially Immune Checkpoint Inhibitors (ICI), are standard of care therapy in non-small cell lung cancers (NSCLC); however, a significant number of patient tumors fail to respond, or develop resistance. …”
    Save to List
    Saved in:
  6. 466
    Table 6_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.xlsx

    Table 6_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.xlsx by Joanna Palade (17712960)

    Published 2025
    “…Introduction<p>Immune-based agents, especially Immune Checkpoint Inhibitors (ICI), are standard of care therapy in non-small cell lung cancers (NSCLC); however, a significant number of patient tumors fail to respond, or develop resistance. …”
    Save to List
    Saved in:
  7. 467
    Table 2_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.xlsx

    Table 2_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.xlsx by Joanna Palade (17712960)

    Published 2025
    “…Introduction<p>Immune-based agents, especially Immune Checkpoint Inhibitors (ICI), are standard of care therapy in non-small cell lung cancers (NSCLC); however, a significant number of patient tumors fail to respond, or develop resistance. …”
    Save to List
    Saved in:
  8. 468
    Table 1_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.xlsx

    Table 1_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.xlsx by Joanna Palade (17712960)

    Published 2025
    “…Introduction<p>Immune-based agents, especially Immune Checkpoint Inhibitors (ICI), are standard of care therapy in non-small cell lung cancers (NSCLC); however, a significant number of patient tumors fail to respond, or develop resistance. …”
    Save to List
    Saved in:
  9. 469
    Image 2_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.jpg

    Image 2_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.jpg by Joanna Palade (17712960)

    Published 2025
    “…Introduction<p>Immune-based agents, especially Immune Checkpoint Inhibitors (ICI), are standard of care therapy in non-small cell lung cancers (NSCLC); however, a significant number of patient tumors fail to respond, or develop resistance. …”
    Save to List
    Saved in:
  10. 470
    Table 5_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.xlsx

    Table 5_NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer.xlsx by Joanna Palade (17712960)

    Published 2025
    “…Introduction<p>Immune-based agents, especially Immune Checkpoint Inhibitors (ICI), are standard of care therapy in non-small cell lung cancers (NSCLC); however, a significant number of patient tumors fail to respond, or develop resistance. …”
    Save to List
    Saved in:
  11. 471
    The model in which the PoFbx23 is required in activating PoAce1 to control the expression of target genes.

    The model in which the PoFbx23 is required in activating PoAce1 to control the expression of target genes. by Zhongjiao Liu (11877464)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 472
    Data that underlies the TAP-MS of three Ace1-TAP samples.

    Data that underlies the TAP-MS of three Ace1-TAP samples. by Zhongjiao Liu (11877464)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 473
    Data that underlies the ChIP-qPCR in this paper.

    Data that underlies the ChIP-qPCR in this paper. by Zhongjiao Liu (11877464)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 474
    The results of TAP-MS using transcription factor PoAce1 as bait.

    The results of TAP-MS using transcription factor PoAce1 as bait. by Zhongjiao Liu (11877464)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 475
    The top proteins interacting with PoAce1 identified through TAP-MS.

    The top proteins interacting with PoAce1 identified through TAP-MS. by Zhongjiao Liu (11877464)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 476
    Ubiquitination of PoAce1 and effect of proteasome inhibitor MG132 on PoAce1.

    Ubiquitination of PoAce1 and effect of proteasome inhibitor MG132 on PoAce1. by Zhongjiao Liu (11877464)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 477
    The result of TAP-MS using PoAce1 as the bait.

    The result of TAP-MS using PoAce1 as the bait. by Zhongjiao Liu (11877464)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 478
    The interaction between PoFbx23A and PoAce1.

    The interaction between PoFbx23A and PoAce1. by Zhongjiao Liu (11877464)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 479
    The phenotype of the Δ<i>ace1</i> and (hemi)cellulase production of various mutants.

    The phenotype of the Δ<i>ace1</i> and (hemi)cellulase production of various mutants. by Zhongjiao Liu (11877464)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 480
    Subcellular localization of PoFbx23A and PoAce1.

    Subcellular localization of PoFbx23A and PoAce1. by Zhongjiao Liu (11877464)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: